/
/
Immunity Unveiled on Open Research Europe

Immunity Unveiled on Open Research Europe

IMMUPARKNET WG5 article entitled “IMMUnity Unveiled: A Translational NETwork for tackling PARKinson’s Disease – IMMUPARKNET” has just been published on Open Research Europe

The Open Letter article by Mitilda Gugu and Shubhra Acharya et al. and led by WG5 leader, Inês Figueira, and by the Action chair, Cristoforo Comi, focuses on the main objectives of IMMUPARKNET COST Action and highlights the major knowledge gaps in immunity in Parkinson disease.

Parkinson’s disease (PD) affects more than one million people in the EU. It currently has no definitive cure, meaning that patients rely only on symptomatic treatments, which themselves are burdened by side effects. The need for advancements in both knowledge and available treatments is thus strongly felt by patients, caregivers, and health operators. This unmet need sparked the idea of orchestrating a collaborative effort via a common network – IMMUPARKNET (The role of IMMUnity in tackling PARKinson’s disease through a Translational NETwork).

Although widely recognized, the role of immunity in the onset and development of PD is still unclear. The main goal of IMMUPARKNET is to fill this knowledge gap by establishing an innovative, interdisciplinary research network and fostering exchanges of expertise among specialists from different countries and institutions.

You can read the full article here.

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

Latest Updates

Senza titolo

IMMUPARKNET COST Action recently concluded the first training school entitled “Models for Parkinson’s Disease: From Basics to Translation” held at the Faculty of Health Sciences,...

Figure 1 COST

It is with great pleasure that we anounce that Work Group 1’s IMMUPARKNET paper has been published in Brain, entitled: “The immune system in Parkinson’s...

The Art of Living

Short-term Scientific Missions (STSM) are institutional visits aimed at supporting individual mobility and fostering collaborations by allowing scientists to visit an institution and contribute to...

WG2 animal

We’re thrilled to share the latest publication from our Working Group 2 (WG2) at IMMUPARKNET COST Action 21117! Entitled “Experimental Models to Study Immune Dysfunction...

IMG_7150

🎉 Exciting News from IMMUPARKNET COST Action 21117 Annual Meeting! 🎉 This year’s IMMUPARKNET COST Action Annual Conference took place in the beautiful city of...

things to do in Belgrade

This year IMMUPARKNET COST Action Annual Conference will take place in the beatiful city of Belgrade, Republic of Serbia, at the Royal Inn Hotel, from...